Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc.
Bullboard Posts
User Avatar Image
(1)
•••
Comment by Viking49on Jan 15, 2018 1:29pm
184 Views
Post# 27360386

RE:Aph vs weed

RE:Aph vs weed
Leggy67 wrote: It’s clear that these are the two heavyweights in this sector.  So will we see a day where aph passes weed in sp and valuation?  

I think it’s a possibility- aph just made a big move- your move now weed !


Aphria is profitable and will have exponential growth over the next couple of years.

Weed has not demonstrated profitability and I have my doubts they will generate one this year.  Their operational costs seem to balloon each quarter and they are using Canopy Rivers to water down revenues to Canopy Growth in future deals.  WEEDS expansion execution has been nothing to get excited about so far.  Last quarter they only produced 4167 kg of bud and equivalents......very poor for their advertised grow space.

Investors that lose patience jump ship!

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities